Evidence map›Paper›PMID 38912867›Full record

ArticleJournal of applied biomedicine2024

RT-qPCR investigation of post-mortem tissues during COVID-19.

Zhanna Berdygulova, Elina Maltseva, Yuliya Perfilyeva, Anna Nizkorodova, Andrey Zhigailov, Dinara Naizabayeva, Yekaterina O Ostapchuk, Saltanat Kuatbekova, Zhaniya Dosmagambet, Moldir Kuatbek and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of applied biomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Zhanna BerdygulovaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Elina MaltsevaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Yuliya PerfilyevaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Anna NizkorodovaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Andrey ZhigailovAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Dinara NaizabayevaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Yekaterina O OstapchukAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Saltanat KuatbekovaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Zhaniya DosmagambetAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Moldir KuatbekAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Akerke BissenbayAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Alena CherushevaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Akzhigit MashzhanAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Nurshat AbdollaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Sanzhar AshimbekovAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Gulnara IsmagulovaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Andrey DmitrovskiyAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Seidigapbar MamadaliyevAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.
Yuriy SkibaAlmaty Branch of the National Center for Biotechnology, Central Reference Laboratory, Almaty, Kazakhstan.

Funding

Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan AP09259103Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan COVID-19
6 · The paper itself

Abstract

In 2020, there were numerous cases in Kazakhstan with clinical symptoms of COVID-19 but negative PCR results in nasopharyngeal and oropharyngeal swabs. The diagnosis was confirmed clinically and by CT scans (computed tomography). The problem with such negative PCR results for SARS-CoV-2 infection confirmation still exists and indicates the need to confirm the diagnosis in the bronchoalveolar lavage in such cases. There is also a lack of information about confirmation of SARS-CoV-2 infection in deceased patients. In this study, various tissue materials, including lungs, bronchi, and trachea, were examined from eight patients who died, presumably from SARS-CoV-2 infection, between 2020 and 2022. Naso/oropharyngeal swabs taken from these patients in hospitals tested PCR negative for SARS-CoV-2. This study presents a modified RNA isolation method based on a comparison of the most used methods for RNA isolation in laboratories: QIAamp Viral RNA Mini Kit and TRIzol-based method. This modified nucleic acid extraction protocol can be used to confirm SARS-CoV-2 infection by RT-qPCR in the tissues of deceased patients in disputed cases. RT-qPCR with RNA of SARS-CoV-2 re-extracted with such method from post-mortem tissues that were stored at -80 °C for more than 32 months still demonstrated high-yielding positive results.

Indexed as

AutopsyCOVID-19RNA, ViralSARS-CoV-2AdultAgedCOVID-19 Nucleic Acid TestingFemaleHumansLungMaleMiddle AgedNasopharynxReal-Time Polymerase Chain ReactionTracheaRNA, ViralCOVID-19Post-mortem tissuesRNA extractionRT-qPCRSARS-CoV-2

Identifiers

PMID38912867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.